MAP1LC3A and neoplasm: Combining LC3-binding SUPR peptides with carboplatin significantly suppresses tumor growth.431 Future directions include the development of highly selective autophagy-targeting drugs, combinations with immunotherapy, and dynamic intervention strategies based on tumor metabolic states to disrupt tumor dormancy.